ADDvise receives order worth USD 11.3 million
MRC Systems, an ADDvise Group company, has received an order from leading Omani biopharmaceutical company Opal Bio Pharma. The initial order value amounts to USD 11.3 million with an extension option amounting to an additional USD 6.8 million. The order involves the design, supply, installation and validation of cleanroom panelling, HVAC and accessories for a biopharmaceutical production and R&D facility based outside Muscat, Oman. The project is scheduled for completion by the end of 2025. “One of the Group’s largest orders to date, this exciting project further cements MRC’